GlassScriptPhysician profile
Rohit Kapoor
NPI 1750392908
$35,551.45
in general payments reported to CMS, 2019-2025
90 companies · $7,584 in 2025
The $7,584 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $1,637 · 2021: $2,255 · 2022: $2,679 · 2023: $8,581 · 2024: $11K · 2025: $7,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $12K · Long Term Medical Supply Or Device Loan: $1,280 · Education: $1,060 · Travel and Lodging: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,277.00 |
| Food and Beverage | $12,157.18 |
| Long Term Medical Supply Or Device Loan | $1,279.73 |
| Education | $1,059.80 |
| Travel and Lodging | $699.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $5,317.03 | 2019-2025 | Padcev |
| Astrazeneca Pharmaceuticals LP | $3,136.64 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Astellas Pharma US INC | $2,795.46 | 2021-2025 | Padcev, Xtandi, Xospata |
| Novartis Pharmaceuticals Corporation | $2,791.94 | 2019-2025 | Kisqali |
| Eisai INC. | $2,663.27 | 2019-2025 | |
| Janssen Biotech, INC. | $2,011.31 | 2019-2025 | Erleada, Tecvayli, Rybrevant |
| Daiichi Sankyo INC. | $1,594.31 | 2021-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $1,523.20 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Aveo Pharmaceuticals, INC. | $1,272.39 | 2021-2025 | Fotivda |
| E.R. Squibb & Sons, L.L.C. | $848.40 | 2019-2025 | Opdivo, Krazati, Eliquis |
| Pfizer INC. | $847.51 | 2019-2025 | |
| Incyte Corporation | $808.05 | 2020-2025 | Jakafi, Monjuvi, Zynyz |
| Genzyme Corporation | $769.78 | 2019-2025 | |
| Genentech USA, INC. | $621.30 | 2019-2025 | Venclexta, Tecentriq, Lunsumio |
| Amgen INC. | $586.01 | 2020-2025 | Kyprolis, Blincyto, Kyprolis |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $535.19 | 2019-2025 | Ninlaro, Iclusig, Alunbrig |
| Sobi, INC | $452.55 | 2022-2025 | |
| Puma Biotechnology, INC. | $364.78 | 2020-2025 | |
| Celgene Corporation | $325.18 | 2021-2025 | Reblozyl, Opdivo |
| Lilly USA, LLC | $288.78 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Regeneron Healthcare Solutions, INC. | $280.99 | 2020-2025 | Libtayo, Lynozyfic |
| Karyopharm Therapeutics INC. | $268.40 | 2022-2025 | Xpovio |
| Bayer Healthcare Pharmaceuticals INC. | $227.90 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $217.22 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Glaxosmithkline, LLC. | $192.67 | 2021-2025 | Ojjaara, Blenrep, Jemperli |
| Genetix Biotherapeutics INC | $185.26 | 2023 | |
| Array Biopharma INC | $174.34 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Gilead Sciences, INC. | $172.92 | 2023-2025 | Trodelvy |
| Abbvie INC. | $171.42 | 2019-2024 | |
| Ipsen Biopharmaceuticals, INC | $159.97 | 2021-2025 | Onivyde, Somatuline Depot |
| Emd Serono, INC. | $157.15 | 2019-2025 | Bavencio |
| Janssen Pharmaceuticals, INC | $156.69 | 2019-2023 | Xarelto |
| Dova Pharmaceuticals | $151.10 | 2019-2021 | |
| Morphosys, US INC. | $145.12 | 2021-2023 | Monjuvi |
| Foundation Medicine, INC. | $138.44 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $137.27 | 2020-2025 | |
| Tersera Therapeutics LLC | $136.45 | 2022-2024 | Xermelo, Zoladex |
| Epizyme, INC. | $131.64 | 2021 | |
| Agios Pharmaceuticals, INC. | $130.79 | 2023-2025 | Pyrukynd |
| Global Blood Therapeutics, INC. | $128.63 | 2020-2022 | |
| Blueprint Medicines Corporation | $128.56 | 2023-2025 | Ayvakit |
| Taiho Oncology, INC. | $115.20 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $113.54 | 2019-2025 | Ultomiris, Soliris |
| Teva Pharmaceuticals USA, INC. | $110.94 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $109.60 | 2021-2025 | |
| Azurity Pharmaceuticals, INC. | $105.22 | 2024-2025 | Danziten, Vivimusta |
| Adc Therapeutics America, INC. | $98.83 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $92.90 | 2023-2025 | Orgovyx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.54 | 2022-2024 | Gilotrif |
| Mirati Therapeutics, INC. | $74.00 | 2023-2024 | Krazati |
| Immunocore Limited | $73.48 | 2025 | Kimmtrak |
| Cti Biopharma Corp. | $73.05 | 2022-2023 | Vonjo |
| Fennec Pharmaceuticals, INC. | $71.64 | 2023-2025 | Fyarro, Pedmark |
| Beone Medicines USA, INC. | $64.23 | 2025 | Brukinsa, Tevimbra |
| Kyowa Kirin, INC. | $62.40 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $60.04 | 2022-2025 | Odomzo, Yonsa |
| Pharmaessentia USA Corporation | $59.74 | 2025 | Besremi |
| Legend Biotech USA INC. | $59.45 | 2025 | Carvykti |
| Stemline Therapeutics INC. | $56.84 | 2023-2024 | Orserdu |
| Pharmacosmos Therapeutics INC. | $55.78 | 2025 | Monoferric |
| Alnylam Pharmaceuticals INC. | $55.69 | 2021-2022 | |
| Acrotech Biopharma INC. | $55.53 | 2021-2024 | Beleodaq |
| Kite Pharma, INC. | $54.53 | 2020-2025 | Yescarta |
| Helsinn Therapeutics (U.S.), INC. | $48.40 | 2019-2021 | |
| Secura Bio, INC. | $48.16 | 2020-2022 | |
| Geron Corporation | $44.92 | 2025 | Rytelo |
| Caris Mpi, INC. | $38.99 | 2025 | Mi Cancer Seek |
| Sirtex Medical INC | $35.65 | 2023-2024 | Sir-Spheres Microspheres |
| Coherus Oncology, INC. | $33.50 | 2020 | |
| Beigene USA, INC. | $31.30 | 2020 | |
| Amag Pharmaceuticals, INC. | $31.17 | 2021 | |
| Tactile Systems Technology INC | $28.99 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $28.66 | 2019 | |
| Clovis Oncology, INC. | $27.61 | 2019-2021 | |
| Emmaus Medical, INC. | $26.93 | 2022 | |
| Fresenius Kabi USA, LLC | $26.49 | 2024 | Stimufend |
| Syndax Pharmaceuticals, INC. | $26.48 | 2025 | |
| Springworks Therapeutics, INC. | $25.57 | 2025 | Gomekli |
| Mylan Institutional INC. | $24.59 | 2019-2020 | |
| Roche Diagnostics Corporation | $24.33 | 2020 | |
| Iovance Biotherapeutics, INC. | $23.15 | 2025 | Amtagvi |
| Spectrum Pharmaceuticals INC. | $22.72 | 2024 | Rolvedon |
| Pharmacyclics LLC, An Abbvie Company | $22.01 | 2021 | |
| Genmab U.S., INC. | $16.64 | 2023 | Epkinly |
| Eusa Pharma (US) LLC | $15.08 | 2019 | |
| Innate Pharma, INC | $14.46 | 2020 | |
| Medtronic USA, INC. | $14.17 | 2019 | |
| Sandoz INC. | $13.71 | 2020 | |
| Verastem, INC. | $12.59 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Padcev $7,137Lenvima $2,159Imfinzi $2,025Kisqali $1,464Fotivda $1,091Keytruda $824Erleada $391Lynparza $372Reblozyl $352Tecvayli $349Enhertu $338Rybrevant $269Pluvicto $261Venclexta $254Sarclisa $254Monjuvi $248Jakafi $245Darzalex $220Libtayo $214Scemblix $207Welireg $206Xpovio $201Xtandi $190Balversa $187Akeega $187Zynteglo $185Tukysa $181Ibrance $175Elrexfio $172Doptelet $169Tecentriq $162Ayvakit $153Orgovyx $149Opdivo $148Braftovi $138Mektovi $138Verzenio $138Onivyde $132Ninlaro $121Talvey $119Adcetris $118Tavalisse $116Rezlidhia $116Calquence $114Jaypirca $113Vonjo $112Lorbrena $112Xalkori $111Pyrukynd $110Stivarga $108Vitrakvi $108Krazati $104Ojjaara $103Zepzelca $93.09Trodelvy $91.38Xarelto $90.87Lunsumio $87.58Polivy $87.58Lonsurf $85.64Inqovi $85.64Zynyz $82.83Wayrilz $82.45Iclusig $79.38Kimmtrak $73.48Jevtana $70.18Tibsovo $67.11Fabhalta $64.70Nerlynx $63.31Gilotrif $63.28Oxbryta $61.08Tivdak $60.05Besremi $59.74Danziten $59.65Carvykti $59.45Xospata $57.09Orserdu $56.84Columvi $56.49Gazyva $56.49Talzenna $56.29Monoferric $55.78Somatuline Depot $55.71Vyloy $55.66Alunbrig $53.99Ultomiris $52.99Tasigna $50.68Kyprolis $48.67Lutathera $47.25Soliris $47.02Eliquis $46.38Brukinsa $45.64Vivimusta $45.57Rytelo $44.92Tagrisso $43.58Xermelo $42.17Nubeqa $41.38Piqray $40.84Fyarro $40.80Odomzo $40.31Zoladex $39.42Synagis $39.16
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.